Organon reinforces commitment to women’s health beyond reproductive health

The fact that women’s health has long been underprioritized is common knowledge. Organon, with roots going back to 1923 and having sharpened its focus on women’s health post its 2021 spinoff from Merck & Co., aims to address significant gaps in treatment and care. “Our commitment to women’s health is not just a part of our corporate strategy; it’s at the core of who we are as a company,” said Dr. Juan Camilo Arjona Ferreira, chief medical officer at the company, in a recent interview. 

Organon sees women’s health as encompassing more than just reproductive issues. “It’s a continuum that spans a woman’s entire life,” said Arjona, a gynecologist by training. “There’s plenty of opportunities across the board because women’s health has been understudied and underappreciated.”

Organon’s approach to women’s health challenges

Dr. Juan Camilo Arjo…

Read more
  • 0

‘Itty bitty’ falloposcope imaging device used inside fallopian tubes for the first time

University of Arizona BIO5 Institute Director Jennifer Barton developed the high-resolution falloposcope. [Photo courtesy of the University of Arizona]

After years of development, University of Arizona researchers have captured their first images inside fallopian tubes with a new device that could be used to search for early signs of ovarian cancer before it spreads.

University of Arizona BIO5 Institute Director Jennifer Barton developed the high-resolution falloposcope, which has a diameter of only 0.8 mm.

“It’s itty bitty,” she said in a news release. “You just couldn’t have fabricated something like this, even six, seven years ago.”

Dr. John Heusinkveld has used the falloposcope since September to look inside the fallopian tubes of four volunteers who were having their tubes removed for non-cancer reasons.

“This is the first endoscope that can fi…

Read more
  • 0